Maternal & Infant Health
World's First AI Platform to Predict Maternal and Infant Health Risks.
By putting Artificial Intelligence at the intersection of medicine, biology and demographics, our algorithms can scan trillions of data points to detect and quantify possible health risks during pregnancies. The risks detected are quantified as MIHIC (Maternal, Infant Health Insights and Cognitive intelligence) Scores. These Scores can help caregivers, payers, governments, pharmaceutical research and pregnant mothers to understand the extent of risk and the factors contributing to elevated risk levels. The key features of MIHIC include:
- Detecting the propensity of more than 47 maternal, fetal and infant risks in pregnant mothers.
- Risks determined based on comprehensive analysis of medical, clinical, social, lifestyle, genetic and radiological determinants.
- Longitudinal progression of MIHIC scores throughout the pregnancy.
- Intuitive visual dashboards to detect and manage high-risk populations.
What is MIHIC ?
CognitiveCare’s Maternal and Infant Health Solution (MIHIC) delivers the propensity of 47 Maternal, Fetal and Infant health risks and outcomes in pregnant mothers. Our neural networks take clinical, medical, social, lifestyle, genetic and radiological determinants of pregnant mothers to spot early signs of any specific symptoms or outcomes and deliver a precise MIHIC quantifying the individual risk as well as the overall risk to the mother. MIHIC scores can help detect and ascertain the extent of risks at an early stage and determine the right intervention to prevent/manage those risks.
Want to know how MIHIC works ? Click Here
Latest News, Featured Content, National & Global Awards, Reseach, Podcast and much more insights of CognitiveCare
PV and Suresh, launched CognitiveCare to build it as a primary conduit for early detection of diseases, health risks and outcomes. CognitiveCare can transform healthcare from a reactive and episodic paradigm to a pro-active and comprehensive disease detection opportunity. PV and Suresh collectively bring unparalleled expertise spanning - medical research and practice; artificial intelligence and advanced computing; drug discovery and clinical trials; patient safety and adverse events detection. Their vision and passion guides us to undertake cutting edge work in medicine, biology and AI and provide our customers with some of the most innovative and impactful solutions